Robert Chess, Director at Twist Bioscience Corp (TWST), sold 6,299 shares at $51.70 ($326K) on 2024-12-05, disclosed to the SEC on 2024-12-30.
Scheduled sale ($326k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.70 | 2,795 | $145K | 44.3% |
| 2 | $51.70 | 2,795 | $145K | 44.3% |
| 3 | $52.45 | 709 | $37K | 11.4% |
| Total | $51.78 avg | 6,299 | $326K | 100% |
| Filing → |
| TWST | SELL | 2026-02-18 | $105K | — | Filing → |
| TWST | SELL | 2025-02-11 | $312K | — | Filing → |
| TWST | SELL | 2025-01-10 | $250K | — | Filing → |